FIELD: biochemistry. SUBSTANCE: method involves addition of anthraquinone-1,5-disulfoacid or its salt in combination with alkaline metal to a reaction mixture of an enzymatic acylation followed by if necessary acidification with hydrochloric acid to isolate cefaclor/anthraquinone salt-1,5- -disulfoacid at ratio 1:2. EFFECT: improved effectiveness of isolation, decreased cost of a procedure. 9 cl, 1 tbl, 3 ex
Title |
Year |
Author |
Number |
BICYCLIC COMPLEXES BETA-LACTAM/HYDROXYBENZOIC ACID, METHODS OF BETA-LACTAMS SYNTHESIS |
1994 |
- Dzhejn Godde Amos
- Dzhozef Majkl Indelikato
- Kehrol Ehlejn Pasini
- S'Juzn Mehri Rojtsel'
|
RU2134265C1 |
METHOD OF PREPARING HEMCITABIN HYDROCHLORIDE |
1995 |
|
RU2154648C2 |
TRIPEPTIDE DERIVATIVES AS R- OR RS-FORMS OR THEIR PHARMACEUTICALLY ACCEPTABLE NONTOXIC SALTS, PHARMACEUTICAL COMPOSITION |
1991 |
- Paul Dehvid Gesellchen[Us]
- Robert Teodor Shuman[Us]
|
RU2077538C1 |
TRIPEPTIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS OR SOLVATES, PHARMACEUTICAL COMPOSITION SHOWING INHIBITING ACTIVITY WITH RESPECT TO THROMBIN AMIDASE |
1994 |
- Pol Dehvid Gezellchen[Us]
- Robert Teodor Shuman[Us]
|
RU2105010C1 |
METHOD OF SYNTHESIS OF (S)--1÷1-N,N-DIMETHYL-3-(1-NAPHTHALINYL- -HYDROXY)-3-(2-THIENYL)-PROPANEAMINE AND (S)-±-N,N-DIMETHYL- -3-(1-NAPHTHALINYLHYDROXY)-3-(2-THIENYL)-PROPANEAMINE PHOSPHATE |
1994 |
|
RU2127269C1 |
PIPERIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY AS ANTAGONIST OF OPIOID PERIPHERAL ACTION |
1992 |
- Baddi Judzhin Kantrell[Us]
- Dennis Majkl Tsimmerman[Us]
|
RU2076863C1 |
CEPHALOSPORIN DERIVATIVES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION |
1992 |
- Robert Dzhon Ternanski[Us]
|
RU2104280C1 |
3,4,4-TRISUBSTITUTED PIPERIDINYL-N-ALKYLCARBOXYLATES AND INTERMEDIATE COMPOUNDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION |
1994 |
- Skott Alan Frehnk
- Duglas Ehdvard Preter
- Dzheffri Alan Uord
- Dzhon Arnol'D Verner
|
RU2145958C1 |
USE OF ISOXAZOLE DERIVATIVES FOR TREATMENT OF PATIENTS WITH IRRITABLE BOWEL SYNDROME (MUCOUS COLITIS) AND A PHARMACEUTICAL COMPOSITION |
1993 |
- Dzhehsvont Singkh Gidda
- Dzhon Menert Skaus
|
RU2127111C1 |
CRYSTALLINE ANHYDROUS FORM OF LORACARBEF AND METHOD OF PREPARING LORACARBEF MONOHYDRATE (VARIANTS) |
1996 |
- Vill'Jam Karl Khenning
- Teodor R. Staut
|
RU2160261C2 |